The lab Miracs is focused on the development of novel molecular imaging tracers including radiopharmaceuticals and optical dye conjugated small molecules for the diagnosis and treatment of diseases. Not only medical radionuclide 18F, 11C, 123I, 131I, and 13N but also emerging radionuclides, such as 68Ga, 64Cu, and 89Zr were used to synthesize PET radiotracers for imaging. Furthermore, we are aimed to develop novel imaging strategies to address unmet needs of clinical settings.